The prevalence of pathologic conditions of the brain associated with Alzheimer disease increases strongly with age. Little is known about the distribution and clinical significance of preclinical biomarker staging in the oldest old, when most individuals without dementia are likely to have positive biomarkers.
MAIN OUTCOMES AND MEASURES
CONCLUSIONS AND RELEVANCE In the oldest old without dementia, presence of either or both Aβ and hippocampal atrophy is typical (>75%). Isolated hippocampal volume atrophy is associated only with greater decline in memory. However, isolated Aβ is associated with decline in memory plus language and executive functions. These findings suggest different underlying pathophysiologic processes in the Aβ termed suspected non-Alzheimer disease pathophysiology (SNAP). The 2-feature biomarker approach has been applied to study participants with normal cognition (NC) and mild cognitive impairment (MCI). [3] [4] [5] [6] [7] [8] [9] [10] The characterization of SNAP has triggered debate about its pathophysiologic basis and its role in cognitive decline and progression to dementia. 11 Cross-sectionally, 10, [20] [21] [22] In this study, we applied the 2-feature biomarker grouping method to compare groups defined by Aβ deposition and evidence of ND (hippocampal atrophy) on cognitive decline across various cognitive domains during longterm follow-up, with a mean of 12.2 years.
Methods

Participants
Participants were a subgroup of the Ginkgo Evaluation of Memory (GEM) study, 23, 24 conducted from 2000 to 2008, who were enrolled in the subsequent Ginkgo Evaluation of Memory Study (GEMS) Imaging Sub-Study (details of which have been previously described). 25 Of 966 participants of the GEM study at the Pittsburgh, Pennsylvania, site, 197 continued in 2009 with the GEMS Imaging Sub-Study, which included Pittsburgh Compound B positron emission tomography (PiB-PET) and magnetic resonance imaging (MRI). The study inclusion criterion was completion of the GEM parent study. Exclusion criteria were dementia at the completion of the GEM parent study and contraindications for neuroimaging. 25 Of the 197 participants in the 
Neuroimaging
Positron emission tomography data were acquired for 20 minutes (4 × 5-minute frames) beginning 50 minutes after injection of a mean (SD) of 15 (1.5) mCi of PiB on a Siemens/ Computer Technology Imaging emission computerized axial tomography high-resolution plus scanner in 3-dimensional imaging mode (63 planes with slice width of 2.4 mm). Retention of PiB was measured over the 50-to 70-minute scan interval and scaled to the injected dose and body mass to generate standardized uptake values (SUVs). The SUVs were then normalized to the SUV of the cerebellum reference region to generate SUV ratio (SUVR) measures of PiB retention. Using an iterative mild outlier cutoff method based on an independent sample of 62 controls, 21 we define Aβ-negative and Aβ-positive status by a global cortical measure (mean of the frontal, anterior cingulate, precuneus, parietal, and temporal cortices) with a cutoff of 1.57 SUVR units. Structural 1.5-T MRI images (General Electric Signa) were acquired, from which the hippocampal volume (HV) was derived and normalized to total intracranial volume. w-Scores were calculated based on an independent reference group of 77 NC individuals (age range, 45-89 years) adjusted for sex and age. Neurodegeneration negative was defined as a w-score less than −0.9063, reflecting 85% sensitivity to AD generated from
Key Points
Question Do domain patterns of long-term cognitive decline in the oldest old differ by neuroimaging biomarker status?
Findings In this longitudinal study, 175 adults without dementia who were older than 80 years were followed up a mean of 12.2 years, with positron emission tomography and magnetic resonance imaging completed in the middle of the observation period. Isolated hippocampal atrophy was associated only with greater decline in memory, while isolated amyloid β was associated with decline in memory plus language and executive functions.
Meaning These findings suggest different pathophysiologic processes underlying preclinical biomarkers of Alzheimer disease in the oldest old. 
Cognitive Assessment
Statistical Analysis
Linear mixed models with a fixed factor of time, quadratic time, and biomarker group as well as their linear and quadratic interactions (when significant) were used to estimate the rate of cognitive decline in neuropsychological test scores for the entire observational period. A random intercept and slope were included with an unstructured covariance to account for the repeated observation structure of the data. The Satterthwaite method 31 was used for computing degrees of freedom. Models were adjusted for age, sex, and years of education. Primary analyses included all 175 participants, adjusted for age, sex, and years of education. The Aβ/ND status group × time interaction term was used to reflect difference in the rates of cognitive performance decline over time relative to the reference group, which was Aβ − /ND − status. The addition of quadratic time and quadratic interaction effects were tested using likelihood ratio test between the models with and without these terms and compared with the corresponding χ 2 degrees of freedom. The quadratic interactions reflect accelerating or decelerating decline rates compared with the reference group. Secondary analyses included only participants with normal cognitive status (n = 140) at the time of imaging. A sensitivity analysis examined shifting the baseline of cognitive trajectories to the time of imaging (2009). Since the number of cognitive measurements was reduced, time was modeled as a linear term only in these models.
Results
Demographic and Clinical Status at Baseline and the Time of Imaging
At the time of imaging (2009) When excluding participants with MCI at the time of imaging, results were highly similar, as shown in Table 3 . A total of 38 of the 140 patients with NC (27.1%) were classified as Aβ showed steeper decline in TMT B, CVLT learning trials and delayed recall, and semantic fluency.
Change Over Time in Neuropsychological Test Scores
In the sensitivity analysis shifting the baseline of cognitive trajectories to the time of imaging, patterns of results were generally similar but with fewer significant contrasts. Differences to the primary analyses ( 
Discussion
This study compares long-term cognitive trajectories for a mean of 12 years of biomarker groups classified by Aβ deposition and hippocampal atrophy near the middle of the cognitive trajectories. Although the study design is not typical, the duration of neuropsychological observation is among the longest, 7,17,18,32 to our knowledge. Furthermore, the participants were among the oldest old; thus, the study expands the current literature investigating ND and Aβ deposition in older adults without dementia. The distribution of the biomarker groups is generally consistent with previous observations and prediction. At the time of imaging, the mean (SD) age of this study cohort was 86.0 (2. ) exhibit steeper decline for a longer observation period, including 8 years of prospective follow-up, on these cognitive measures. The association between Aβ and long-term decline in extramemory cognitive processes, particularly executive functions and language, is consistent with an established literature showing that executive function and semantic fluency deficits are very early predictors of AD. [41] [42] [43] This study included individuals with both NC and MCI at the time of imaging. When restricting the sample to participants with NC in 2009, however, the results were highly similar, indicating that the larger cohort findings were not driven by the MCI group. Because the imaging performed in 2009 lagged behind the initial cognitive assessment performed between 2000 and 2002, biomarker status at initial intake was unknown. In a sensitivity analysis that excluded all cognitive pal atrophy; thus, they concluded that SNAP is more likely to reflect inherent variability in brain structure than early AD. Our cognitive slope findings support the notion that SNAP is dissimilar to early AD in that no domains other than memory decline in SNAP, whereas isolated Aβ is associated with extramemory decline (namely, language and executive function). We observed some evidence of a progressive process in SNAP (ie, visual memory decline greater than the nonpathologic reference), whereas in the younger cohort (mean age, 66 years), SNAP was not associated with faster rate of hippocampal atrophy than other groups. 46 These findings further the understanding of AD pathophysiologic conditions in the oldest old. Postmortem studies indicate that after 80 years of age, presence of Aβ plaques (and neurofibrillary tangles) no longer discriminates between clinical dementia and nondementia cases. 47, 48 Furthermore, pathologic heterogeneity of dementia increases with advanced age. 49 Weakening of associations between Aβ and cognition with advanced age suggests that AD may be a different disease above 80 years of age than below. If true, the argument has been made that Aβ is likely a misguided therapeutic target, as it may reflect an inherent process of advanced aging. 50, 51 As reported previously in this same oldest old cohort, Aβ deposition was not associated with the incidence of dementia during 2 years among the highest-risk participants with MCI (although it was associated with incidence of dementia among all participants). 52 
Limitations
This study has some limitations. Because the imaging lagged behind the initial cognitive assessment, biomarker status at initial intake was unknown. In addition, ND was operationalized only by HV, simplifying the complexity of ND biomarkers. Finally, the participants were relatively highly educated and mostly of white European descent; the findings may not generalize to other populations.
Conclusions
In the oldest old, the presence of both Aβ deposition and reduced hippocampal volume is common and confers the greatest risk for cognitive decline across domains. Neither biomarker abnormality is benign in the ninth and 10th decades of life. Isolated Aβ deposition is associated with decline in memory, executive functions, and some aspects of language, while isolated hippocampal atrophy is associated only with decline in memory. Suspected non-Alzheimer disease pathophysiology and isolated Aβ exhibit distinct cognitive decline profiles, which suggests different underlying pathophysiologic processes. 
